Mortality predictors in a cohort of patients with COVID-19 admitted to a large tertiary hospital in the city of São Paulo, Brazil: a retrospective study

Abstract BACKGROUND: There is discrepant information across countries regarding the natural history of patients admitted to hospitals with coronavirus disease (COVID-19), in addition to a lack of data on the scenario in Brazil. OBJECTIVE: To determine the mortality predictors in COVID-19 patients admitted to a tertiary hospital in São Paulo, Brazil. DESIGN AND SETTING: A retrospective analysis of medical records of COVID-19 patients admitted to the Hospital Central da Irmandade da Santa Casa de Misericórdia of São Paulo. METHODS: Overall, 316 patients with laboratory-confirmed COVID-19 between March 1, 2020, and July 31, 2020, were included. The analysis included the baseline characteristics, clinical progression, and outcomes. RESULTS: The mortality rate of the sample was 51.27%. Age ≥ 60 years was determined as a risk factor after multivariate logistic regression analysis. Patients with an oxygen (O2) saturation ≤ 94% upon admission accounted for 87% of the deaths (P < 0.001). Vasoactive drugs were used in 92% (P < 0.001) of patients who progressed to death, and mechanical ventilation was employed in 88% (P < 0.001) of such patients. However, patients who received corticosteroids concomitantly with mechanical ventilation had a better prognosis than those who did not. The progressive degree of pulmonary involvement observed on chest computed tomography was correlated with a worse prognosis. The presence of thrombocytopenia has been considered as a risk factor for mortality. CONCLUSION: The main predictors of in-hospital mortality after logistic regression analysis were age, O2 saturation ≤ 94% upon admission, use of vasoactive drugs, and presence of thrombocytopenia.

Mortality predictors in a cohort of patients with COVID-19 admitted to a large tertiary hospital in the city of São Paulo, Brazil: a retrospective study.

BACKGROUND: There is discrepant information across countries regarding the natural history of patients admitted to hospitals with coronavirus disease (COVID-19), in addition to a lack of data on the scenario in Brazil. OBJECTIVE: To determine the mortality predictors in COVID-19 patients admitted to a tertiary hospital in São Paulo, Brazil. DESIGN AND SETTING: A retrospective analysis of medical records of COVID-19 patients admitted to the Hospital Central da Irmandade da Santa Casa de Misericórdia of São Paulo. METHODS: Overall, 316 patients with laboratory-confirmed COVID-19 between March 1, 2020, and July 31, 2020, were included. The analysis included the baseline characteristics, clinical progression, and outcomes. RESULTS: The mortality rate of the sample was 51.27%. Age ≥ 60 years was determined as a risk factor after multivariate logistic regression analysis. Patients with an oxygen (O2) saturation ≤ 94% upon admission accounted for 87% of the deaths (P < 0.001). Vasoactive drugs were used in 92% (P < 0.001) of patients who progressed to death, and mechanical ventilation was employed in 88% (P < 0.001) of such patients. However, patients who received corticosteroids concomitantly with mechanical ventilation had a better prognosis than those who did not. The progressive degree of pulmonary involvement observed on chest computed tomography was correlated with a worse prognosis. The presence of thrombocytopenia has been considered as a risk factor for mortality. CONCLUSION: The main predictors of in-hospital mortality after logistic regression analysis were age, O2 saturation ≤ 94% upon admission, use of vasoactive drugs, and presence of thrombocytopenia.

Potentially inappropriate medication use in hospitalized elderly patients.

OBJECTIVE: This study aimed to assess the prevalence of potentially inappropriate medication prescription in hospitalized elderly patients according to the 2019 American Geriatrics Society Beers Criteria. METHODS: This study is a prospective analysis of electronic medical records of elderly patients admitted to the Department of Medicine, Hospital Central da Irmandade da Santa Casa de Misericórdia de São Paulo, between 1 September 2020 and 30 April 2021. RESULTS: A total of 142 patients (85 women and 57 men) with a mean age of 74.5±7.3 years (65-99 years) were assessed. Of these, 108 (76.1%) were elderly (age ≥65 years and <80 years) and 34 (23.9%) long-lived (age ≥80 years). The average length of stay found in the sample was 25.3±28.7 days (between 2 and 235 days), and 102 out of the 140 patients assessed remained in the hospital for up to 29 days. Sixteen drugs considered potentially inappropriate medication were found in the patients' prescriptions, with at least one potentially inappropriate medication having been prescribed to 141 (99.3%) patients. Elderly patients had a mean of 2.57±0.94 potentially inappropriate medication prescribed versus 2.56±0.89 among long-lived patients. The most prescribed potentially inappropriate medication were as follows: regular human insulin as required (85.2%), and omeprazole (73.9%) and metoclopramide as required (61.3%). CONCLUSION: The study sample showed significant percentages of potentially inappropriate medication prescriptions for the elderly admitted to the hospital.

Potentially inappropriate medication use in hospitalized elderly patients

SUMMARY OBJECTIVE: This study aimed to assess the prevalence of potentially inappropriate medication prescription in hospitalized elderly patients according to the 2019 American Geriatrics Society Beers Criteria. METHODS: This study is a prospective analysis of electronic medical records of elderly patients admitted to the Department of Medicine, Hospital Central da Irmandade da Santa Casa de Misericórdia de São Paulo, between 1 September 2020 and 30 April 2021. RESULTS: A total of 142 patients (85 women and 57 men) with a mean age of 74.5±7.3 years (65-99 years) were assessed. Of these, 108 (76.1%) were elderly (age ≥65 years and <80 years) and 34 (23.9%) long-lived (age ≥80 years). The average length of stay found in the sample was 25.3±28.7 days (between 2 and 235 days), and 102 out of the 140 patients assessed remained in the hospital for up to 29 days. Sixteen drugs considered potentially inappropriate medication were found in the patients' prescriptions, with at least one potentially inappropriate medication having been prescribed to 141 (99.3%) patients. Elderly patients had a mean of 2.57±0.94 potentially inappropriate medication prescribed versus 2.56±0.89 among long-lived patients. The most prescribed potentially inappropriate medication were as follows: regular human insulin as required (85.2%), and omeprazole (73.9%) and metoclopramide as required (61.3%). CONCLUSION: The study sample showed significant percentages of potentially inappropriate medication prescriptions for the elderly admitted to the hospital.

Adesão ao tratamento medicamentoso em idosos cardiopatas / Adherencia al tratamiento farmacológico en ancianos con enfermedad cardíaca / Adherence to drug treatment in elderly with heart conditions

Objetivo: Avaliar a adesão ao tratamento medicamentoso em idosos cardiopatas. Método: Pesquisa de campo, descritiva e quantitativa. Consentiram em participar da pesquisa 40 idosos atendidos em um Ambulatório de Cardiogeriatria. A coleta de dados ocorreu de agosto a novembro de 2018, com dados sociodemográficos e clínicos, Avaliação Multidimensional da Pessoa Idosa à avaliação da adesão ao tratamento pelo Brief Medication Questionnaire. Resultados: A idade média foi de 74+9,9 anos do sexo feminino em 57,7% dos idosos. Segundo o BMQ, 90% dos idosos apresentaram algum tipo de barreira para a adesão ao tratamento medicamentoso; 66,7% apresentaram barreiras de 'Regime', 10,2% de 'Crenças' e 89,5% de 'Recordação'. Conclusão: Na avaliação da adesão ao tratamento, segundo o BMQ, as barreiras mais frequentes foram as de 'Recordação', seguidas de 'Regime' e de 'Crenças'. A frequência dos idosos com barreira de 'Recordação' foi maior entre os que utilizavam cinco ou mais medicamentos diários(AU)

Purpose: To evaluate adherence to a drug treatment in elderly patients with heart diseases. Method: This is a descriptive, quantitative field research. Forty elderly people assisted in a Cardiogeriatrics Clinic consented to participate in the research. Data collection took place from August to November 2018 and comprised sociodemographic and clinical data, Multidimensional Assessment of the Elderly, and the assessment of adherence to treatment by the Brief Medication Questionnaire. Results: The mean age was 74 ± 9.9 years and 57.7% of the elderly were women. According to the BMQ, 90% of the elderly had some type of resistance to adhering to drug treatment; 66.7% were due to 'Regime', 10.2% due to 'Beliefs' and 89.5% due to 'Recollection'. Conclusion: In assessing adherence to treatment according to the BMQ, the most frequent reasons against adherence were 'Recollection', followed by 'Regime' and 'Beliefs'. The frequency of elderly people in the "Recollection" group was higher among those who took five or more medications per day.(AU)

Objetivo: Evaluar la adherencia al tratamiento farmacológico en pacientes ancianos con cardiopatía. Método: Investigación de campo, descriptiva y cuantitativa. Cuarenta ancianos atendidos en una Clínica de Cardiogeriatría dieron su consentimiento para participar en la investigación. La recolección de datos se realizó de agosto a noviembre de 2018, con datos sociodemográficos y clínicos, Evaluación Multidimensional del Anciano y la evaluación de la adherencia al tratamiento mediante el Cuestionario Breve de Medicación. Resultados: La edad media fue de 74 + 9,9 años y el 57,7% de los ancianos eran mujeres. Según el BMQ, el 90% de los ancianos tenía algún tipo de barrera para la adherencia al tratamiento farmacológico; El 66,7% tenía barreras de "Régimen", el 10,2% de "Creencias" y el 89,5% de "Recuerdo". Conclusión: Al evaluar la adherencia al tratamiento según BMQ, las barreras más frecuentes fueron las de 'Recuerdo', seguidas de 'Régimen' y 'Creencias'. La frecuencia de las personas mayores con una barrera de "recuperación" fue mayor entre los que usaban cinco o más medicamentos al día(AU)

Beers AGS 2019 criteria in very old hospitalized patients.

OBJECTIVE To define the rates and types of potentially inappropriate medications (PIMs) for older adults according to the Beers AGS 2019 criteria in oldest-old patients (aged ≥80 years) hospitalized in an Internal Medicine ward. METHODS A retrospective analysis of prescriptions from medical records of oldest-old patients hospitalized in an Internal Medicine Teaching-Hospital ward using the Beers AGS 2019 criteria was performed. Data was also collected for gender, mean age, days of hospitalization, presence of feeding tube, delirium, and polypharmacy (≥5 drugs/day). The drugs listed in Table 2 of the Beers criteria were considered PIMs. RESULTS The series comprised 39 very old patients (22 men, 17 women), with a mean age of 86.3±4.7 years and hospitalization of 22.8±21.3 days. All patients were admitted via the Emergency Room. Feeding tube placement and polypharmacy occurred in 84.6% of cases and delirium in 71.8%. The prescription of a total of 16 drugs considered PIM was detected by the Beers AGS 2019 criteria (mean 1.8 ± 1.0 PIM per patient). Main prescribed PIMs were Metoclopramide "if necessary" [IN] (41.0% of cases), Omeprazole (38.5%), Regular Insulin [IN] (23.1%), Haloperidol [IN] (18.0%), Quetiapine and Amiodarone (10% each). CONCLUSION In the present series of oldest-old hospitalized patients, significant rates of PIM were found, especially for drugs prescribed as "If Necessary", thereby increasing the risk of side-effects to that of the common polypharmacy in this age group.

Beers AGS 2019 criteria in very old hospitalized patients

SUMMARY OBJECTIVE To define the rates and types of potentially inappropriate medications (PIMs) for older adults according to the Beers AGS 2019 criteria in oldest-old patients (aged ≥80 years) hospitalized in an Internal Medicine ward. METHODS A retrospective analysis of prescriptions from medical records of oldest-old patients hospitalized in an Internal Medicine Teaching-Hospital ward using the Beers AGS 2019 criteria was performed. Data was also collected for gender, mean age, days of hospitalization, presence of feeding tube, delirium, and polypharmacy (≥5 drugs/day). The drugs listed in Table 2 of the Beers criteria were considered PIMs. RESULTS The series comprised 39 very old patients (22 men, 17 women), with a mean age of 86.3±4.7 years and hospitalization of 22.8±21.3 days. All patients were admitted via the Emergency Room. Feeding tube placement and polypharmacy occurred in 84.6% of cases and delirium in 71.8%. The prescription of a total of 16 drugs considered PIM was detected by the Beers AGS 2019 criteria (mean 1.8 ± 1.0 PIM per patient). Main prescribed PIMs were Metoclopramide "if necessary" [IN] (41.0% of cases), Omeprazole (38.5%), Regular Insulin [IN] (23.1%), Haloperidol [IN] (18.0%), Quetiapine and Amiodarone (10% each). CONCLUSION In the present series of oldest-old hospitalized patients, significant rates of PIM were found, especially for drugs prescribed as "If Necessary", thereby increasing the risk of side-effects to that of the common polypharmacy in this age group.

RESUMO OBJETIVO Definir percentual e tipos de medicamentos potencialmente inapropriados para idosos (MPII) pelos critérios de Beers AGS 2019 em longevos (idade ≥80 anos) hospitalizados em enfermaria de clínica médica. MÉTODO Análise retrospectiva das prescrições de prontuários de longevos internados em enfermaria de clínica médica de hospital terciário pelos critérios de Beers AGS 2019. Outros dados coletados: gênero, idade média, dias de hospitalização, presença de sonda de alimentação, delirium, polifarmácia (≥5 fármacos/dia). Consideraram-se como MPII os fármacos listados na Tabela 2 do referido critério. RESULTADOS Trinta e nove longevos (22 homens, 17 mulheres), idade média 86,3±4,7 anos e 22,8±21,3 dias de hospitalização. A presente casuística foi integralmente admitida pelo pronto-socorro, ocorrendo sonda de alimentação e polifarmácia em 84,6% dos casos e delirium em 71,8%. Detectou-se a prescrição de 16 fármacos considerados MPII pelos critérios de Beers AGS 2019 (média de 1,8±1,0 MPII por paciente). Principais MPII prescritos: metoclopramida, se necessário [SN] (41,0% dos casos), omeprazol (38,5%), insulina regular [SN] (23,1%), haloperidol [SN] (18,0%), quetiapina e amiodarona (10% cada). CONCLUSÃO Na presente casuística, longevos hospitalizados apresentaram percentuais significativos de MPII, notadamente em fármacos indicados como "se necessário", o que aumenta o risco de efeitos colaterais ao fato comum de polifarmácia nessa faixa etária.

Updated geriatric cardiology guidelines of the brazilian society of cardiology ­ 2019 / Atualização das diretrizes em cardiogeriatria da sociedade brasileira de cardiologia ­ 2019

Development: The Department of Geriatric Cardiology of the Brazilian Society of Cardiology (Departamento de Cardiogeriatria da Sociedade Brasileira da Cardiologia) and the Brazilian Geriatrics and Gerontology Society (Sociedade Brasileira de Geriatria e Gerontologia). (AU)

Suplementação mineral e vitamínica em doenças crônicas e de convalescença / Mineral and vitamin supplementation in chronic diseases and convalescence

A síndrome de fadiga crônica (SFC) é uma condição clínica que, apesar de muito prevalente, tem tratamento controverso. A suplementação com substratos como glutamina e vitaminas pode atuar como adjuvante terapêutico. Os autores descrevem um medicamento que pode atender essa finalidade, composto por glutamina 200mg, glutamato de cálcio 250mg, cloridrato de piridoxina 20mg e fosfato de ditetraetilamônio 6mg. São descritas também as ações de cada um dos componentes, e como podem auxiliar na terapêutica da SFC e em períodos de convalescença em diversas condições.

The chronic fatigue syndrome (CFS) is a clinical condition which, although highly prevalent, treatment is controversial and supplementation of substrates such as glutamine and vitamins can act as therapeutic adjuvant. A drug composition that can serve this purpose, the composition is glutamine 200mg, 250mg calcium glutamate, 20mg pyridoxine hydrochloride and phosphate ditetraetilammonium 6mg is described. Also described the actions of each component and how they can assist in the treatment of CFS and in periods of convalescence from various other conditions described.

Fisiopatologia e diagnóstico da hipertensão arterial no idoso: papel da monitorização ambulatorial da pressão arterial e da monitorização residencial da pressão arterial / Fisiopatology and diagnosis of hypertension in the elderly: the role of ambulatory blood pressure monitoring and home blood pressure monitoring

A hipertensão arterial é doença muito prevalente em idosos. Esses pacientes caracterizam um grupo especial, a com alterações fisiopatológicas significativas em razão do c envelhecimento: maior variabilidade da pressão arterial b (PAI, maior prevalência da hipertensão do avental branco h (HABI e presença de hipotensão pós-prandial. O diagnóstico é mais difícil, devendo-se avaliar a PA em várias s situações. O uso da monitorização ambulatorial da pressão IT arterial (MAPA) e da monitorização residencial da pressão arterial (MRPA) podem ser úteis no diagnóstico, no programa e no acompanhamento do idoso hipertenso.